price
EN
NASDAQ · ENGN
enGene Holdings Inc.
Healthcare · Biotechnology
$1.75
Up+$0.07 (+4.17%)
Updated Nov 9, 2026, 3:17 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 455.64M
- P/E ratio
- -10.55
- Dividend yield
- 0.00%
- 52-week range
- $1.40 – $9.00
- Volume
- 1.43M
- Avg. volume
- 1.26M
Price performance · ENGN
ENGN price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
ENGN closed at $1.75 after 20 trading sessions, up 2.94% for the selected period.
- Last close
- $1.75
- Period change
- +2.94%
- Period low
- $1.45
- Period high
- $1.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $1.68 | $1.775 | $1.632 | $1.75 | 1.43M |
| Nov 5, 2026 | $1.70 | $1.71 | $1.65 | $1.68 | 624.43K |
| Nov 4, 2026 | $1.585 | $1.75 | $1.575 | $1.72 | 1.45M |
| Nov 3, 2026 | $1.47 | $1.63 | $1.45 | $1.62 | 937.14K |
| Nov 2, 2026 | $1.55 | $1.55 | $1.45 | $1.45 | 587.19K |
| Oct 30, 2026 | $1.53 | $1.55 | $1.46 | $1.53 | 1.2M |
| Oct 29, 2026 | $1.57 | $1.62 | $1.52 | $1.53 | 690.37K |
| Oct 28, 2026 | $1.54 | $1.5999 | $1.535 | $1.58 | 997.47K |
| Oct 27, 2026 | $1.625 | $1.625 | $1.55 | $1.55 | 365.26K |
| Oct 26, 2026 | $1.57 | $1.625 | $1.554 | $1.58 | 657.82K |
| Oct 23, 2026 | $1.55 | $1.575 | $1.54 | $1.56 | 730.2K |
| Oct 22, 2026 | $1.619 | $1.65 | $1.57 | $1.58 | 554.58K |
| Oct 21, 2026 | $1.68 | $1.681 | $1.59 | $1.63 | 1.11M |
| Oct 20, 2026 | $1.60 | $1.72 | $1.59 | $1.67 | 1.12M |
| Oct 19, 2026 | $1.66 | $1.70 | $1.58 | $1.58 | 783.85K |
| Oct 16, 2026 | $1.73 | $1.7489 | $1.65 | $1.67 | 1.16M |
| Oct 15, 2026 | $1.61 | $1.735 | $1.58 | $1.71 | 1.18M |
| Oct 14, 2026 | $1.60 | $1.62 | $1.56 | $1.56 | 943.53K |
| Oct 13, 2026 | $1.69 | $1.70 | $1.62 | $1.63 | 914.09K |
| Oct 12, 2026 | $1.73 | $1.74 | $1.69 | $1.70 | 462.72K |
Latest ENGN news
The latest Smart Investors Daily articles mentioning ENGN.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…